Analysis of telomerase activity levels in breast cancer: Positive detection at the in situ breast carcinoma stage

Andrzej K. Bednarek, Aysegul Sahin, Andrew Brenner, Dennis A. Johnston, C. Marcelo Aldaz

Research output: Contribution to journalArticle

88 Citations (Scopus)

Abstract

Telomerase activity has been implicated to be associated with most human malignant tumors, including breast cancer. To evaluate possible associations with well-known prognostic factors in breast cancer, we performed a semiquantitative analysis of telomerase activity levels using the very sensitive PCR-mediated telomeric repeat amplification protocol. Telomerase activity was detected in 99 of 104 breast cancer samples analyzed (95.2%), whereas no activity was detected in 10 of 10 adjacent nonmalignant breast tissues. Analysis of five breast fibroadenoma samples revealed telomerase activity in one (20%). In contrast to previous observations, we observed that 100% of stage I breast tumors were positive for telomerase activity. More interestingly, we detected telomerase activity in six of six ductal carcinoma in situ samples (i.e., stage 0). In our semiquantitative analysis of levels of enzymatic activity, we found no statistically significant correlation at the P < 0.05 level between telomerase levels and lymph node metastasis status, estrogen and progesterone receptor status, tumor size, S-phase fraction, and ploidy. The only statistically significant correlation was found with patient age (rho = -0.3; P = 0.03). We observed no statistically significant difference in the telomerase activity levels of early tumors (stages 0 and I) versus more advanced lesions (stages II to IV). Nevertheless, stage IV tumors displayed a tendency for higher telomerase activity levels. In summary, no clear association was observed between telomerase levels and known breast cancer prognostic indicators. However, telomerase detection by the telomeric repeat amplification protocol method, due to its high sensitivity, may be of value in early breast cancer diagnosis and detection, because our data indicate that telomerase reactivation appears to constitute a relatively early event in breast carcinogenesis.

Original languageEnglish (US)
Pages (from-to)11-16
Number of pages6
JournalClinical Cancer Research
Volume3
Issue number1
StatePublished - 1997
Externally publishedYes

Fingerprint

Telomerase
Breast Neoplasms
Breast
Breast Carcinoma In Situ
Fibroadenoma
Neoplasms
Carcinoma, Intraductal, Noninfiltrating
Ploidies
Progesterone Receptors
S Phase
Early Detection of Cancer
Estrogen Receptors
Carcinogenesis
Lymph Nodes
Neoplasm Metastasis

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Analysis of telomerase activity levels in breast cancer : Positive detection at the in situ breast carcinoma stage. / Bednarek, Andrzej K.; Sahin, Aysegul; Brenner, Andrew; Johnston, Dennis A.; Aldaz, C. Marcelo.

In: Clinical Cancer Research, Vol. 3, No. 1, 1997, p. 11-16.

Research output: Contribution to journalArticle

Bednarek, Andrzej K. ; Sahin, Aysegul ; Brenner, Andrew ; Johnston, Dennis A. ; Aldaz, C. Marcelo. / Analysis of telomerase activity levels in breast cancer : Positive detection at the in situ breast carcinoma stage. In: Clinical Cancer Research. 1997 ; Vol. 3, No. 1. pp. 11-16.
@article{1aa1eedd8b194ff68ccc1fe7e0fa396f,
title = "Analysis of telomerase activity levels in breast cancer: Positive detection at the in situ breast carcinoma stage",
abstract = "Telomerase activity has been implicated to be associated with most human malignant tumors, including breast cancer. To evaluate possible associations with well-known prognostic factors in breast cancer, we performed a semiquantitative analysis of telomerase activity levels using the very sensitive PCR-mediated telomeric repeat amplification protocol. Telomerase activity was detected in 99 of 104 breast cancer samples analyzed (95.2{\%}), whereas no activity was detected in 10 of 10 adjacent nonmalignant breast tissues. Analysis of five breast fibroadenoma samples revealed telomerase activity in one (20{\%}). In contrast to previous observations, we observed that 100{\%} of stage I breast tumors were positive for telomerase activity. More interestingly, we detected telomerase activity in six of six ductal carcinoma in situ samples (i.e., stage 0). In our semiquantitative analysis of levels of enzymatic activity, we found no statistically significant correlation at the P < 0.05 level between telomerase levels and lymph node metastasis status, estrogen and progesterone receptor status, tumor size, S-phase fraction, and ploidy. The only statistically significant correlation was found with patient age (rho = -0.3; P = 0.03). We observed no statistically significant difference in the telomerase activity levels of early tumors (stages 0 and I) versus more advanced lesions (stages II to IV). Nevertheless, stage IV tumors displayed a tendency for higher telomerase activity levels. In summary, no clear association was observed between telomerase levels and known breast cancer prognostic indicators. However, telomerase detection by the telomeric repeat amplification protocol method, due to its high sensitivity, may be of value in early breast cancer diagnosis and detection, because our data indicate that telomerase reactivation appears to constitute a relatively early event in breast carcinogenesis.",
author = "Bednarek, {Andrzej K.} and Aysegul Sahin and Andrew Brenner and Johnston, {Dennis A.} and Aldaz, {C. Marcelo}",
year = "1997",
language = "English (US)",
volume = "3",
pages = "11--16",
journal = "Clinical Cancer Research",
issn = "1078-0432",
publisher = "American Association for Cancer Research Inc.",
number = "1",

}

TY - JOUR

T1 - Analysis of telomerase activity levels in breast cancer

T2 - Positive detection at the in situ breast carcinoma stage

AU - Bednarek, Andrzej K.

AU - Sahin, Aysegul

AU - Brenner, Andrew

AU - Johnston, Dennis A.

AU - Aldaz, C. Marcelo

PY - 1997

Y1 - 1997

N2 - Telomerase activity has been implicated to be associated with most human malignant tumors, including breast cancer. To evaluate possible associations with well-known prognostic factors in breast cancer, we performed a semiquantitative analysis of telomerase activity levels using the very sensitive PCR-mediated telomeric repeat amplification protocol. Telomerase activity was detected in 99 of 104 breast cancer samples analyzed (95.2%), whereas no activity was detected in 10 of 10 adjacent nonmalignant breast tissues. Analysis of five breast fibroadenoma samples revealed telomerase activity in one (20%). In contrast to previous observations, we observed that 100% of stage I breast tumors were positive for telomerase activity. More interestingly, we detected telomerase activity in six of six ductal carcinoma in situ samples (i.e., stage 0). In our semiquantitative analysis of levels of enzymatic activity, we found no statistically significant correlation at the P < 0.05 level between telomerase levels and lymph node metastasis status, estrogen and progesterone receptor status, tumor size, S-phase fraction, and ploidy. The only statistically significant correlation was found with patient age (rho = -0.3; P = 0.03). We observed no statistically significant difference in the telomerase activity levels of early tumors (stages 0 and I) versus more advanced lesions (stages II to IV). Nevertheless, stage IV tumors displayed a tendency for higher telomerase activity levels. In summary, no clear association was observed between telomerase levels and known breast cancer prognostic indicators. However, telomerase detection by the telomeric repeat amplification protocol method, due to its high sensitivity, may be of value in early breast cancer diagnosis and detection, because our data indicate that telomerase reactivation appears to constitute a relatively early event in breast carcinogenesis.

AB - Telomerase activity has been implicated to be associated with most human malignant tumors, including breast cancer. To evaluate possible associations with well-known prognostic factors in breast cancer, we performed a semiquantitative analysis of telomerase activity levels using the very sensitive PCR-mediated telomeric repeat amplification protocol. Telomerase activity was detected in 99 of 104 breast cancer samples analyzed (95.2%), whereas no activity was detected in 10 of 10 adjacent nonmalignant breast tissues. Analysis of five breast fibroadenoma samples revealed telomerase activity in one (20%). In contrast to previous observations, we observed that 100% of stage I breast tumors were positive for telomerase activity. More interestingly, we detected telomerase activity in six of six ductal carcinoma in situ samples (i.e., stage 0). In our semiquantitative analysis of levels of enzymatic activity, we found no statistically significant correlation at the P < 0.05 level between telomerase levels and lymph node metastasis status, estrogen and progesterone receptor status, tumor size, S-phase fraction, and ploidy. The only statistically significant correlation was found with patient age (rho = -0.3; P = 0.03). We observed no statistically significant difference in the telomerase activity levels of early tumors (stages 0 and I) versus more advanced lesions (stages II to IV). Nevertheless, stage IV tumors displayed a tendency for higher telomerase activity levels. In summary, no clear association was observed between telomerase levels and known breast cancer prognostic indicators. However, telomerase detection by the telomeric repeat amplification protocol method, due to its high sensitivity, may be of value in early breast cancer diagnosis and detection, because our data indicate that telomerase reactivation appears to constitute a relatively early event in breast carcinogenesis.

UR - http://www.scopus.com/inward/record.url?scp=0031041774&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031041774&partnerID=8YFLogxK

M3 - Article

C2 - 9815531

AN - SCOPUS:0031041774

VL - 3

SP - 11

EP - 16

JO - Clinical Cancer Research

JF - Clinical Cancer Research

SN - 1078-0432

IS - 1

ER -